Vemurafenib Plus Cobimetinib After Radiosurgery in Patients With BRAF-mutant Melanoma Brain Metastases
Clinical trial NCT03430947 · TERMINATED
Trial details
- NCT number
- NCT03430947
- Sponsor
- Technische Universität Dresden
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-01
- Primary completion
- 2023-02-10
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.